KR20060040053A - 혈당의 효율적 조절을 가능케 하는 삼중 기능을 갖는인슐린 펌프 및 이를 보조하는 생리수 시린지를 포함하는인슐린 투여 시스템 - Google Patents
혈당의 효율적 조절을 가능케 하는 삼중 기능을 갖는인슐린 펌프 및 이를 보조하는 생리수 시린지를 포함하는인슐린 투여 시스템 Download PDFInfo
- Publication number
- KR20060040053A KR20060040053A KR1020040089241A KR20040089241A KR20060040053A KR 20060040053 A KR20060040053 A KR 20060040053A KR 1020040089241 A KR1020040089241 A KR 1020040089241A KR 20040089241 A KR20040089241 A KR 20040089241A KR 20060040053 A KR20060040053 A KR 20060040053A
- Authority
- KR
- South Korea
- Prior art keywords
- insulin
- pump
- mode
- syringe
- control device
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 362
- 102000004877 Insulin Human genes 0.000 title claims abstract description 183
- 108090001061 Insulin Proteins 0.000 title claims abstract description 183
- 229940125396 insulin Drugs 0.000 title claims abstract description 181
- 210000004369 blood Anatomy 0.000 title claims abstract description 32
- 239000008280 blood Substances 0.000 title claims abstract description 32
- 238000002347 injection Methods 0.000 title claims abstract description 14
- 239000007924 injection Substances 0.000 title claims abstract description 14
- 230000006870 function Effects 0.000 title claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title description 6
- 239000008103 glucose Substances 0.000 title description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title 1
- 239000011780 sodium chloride Substances 0.000 title 1
- 230000004913 activation Effects 0.000 claims abstract description 35
- 235000012054 meals Nutrition 0.000 claims abstract description 23
- 235000013305 food Nutrition 0.000 claims abstract description 15
- 230000004044 response Effects 0.000 claims abstract description 13
- 230000037406 food intake Effects 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000012423 maintenance Methods 0.000 claims description 8
- 206010012601 diabetes mellitus Diseases 0.000 claims description 7
- 238000000034 method Methods 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 1
- 210000003462 vein Anatomy 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 description 14
- 230000002175 menstrual effect Effects 0.000 description 11
- 230000003914 insulin secretion Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 208000013016 Hypoglycemia Diseases 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 2
- 102000005237 Isophane Insulin Human genes 0.000 description 2
- 108010081368 Isophane Insulin Proteins 0.000 description 2
- LEMUFSYUPGXXCM-JNEQYSBXSA-N caninsulin Chemical compound [Zn].C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3N=CN=C3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1C=NC=N1 LEMUFSYUPGXXCM-JNEQYSBXSA-N 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 244000265913 Crataegus laevigata Species 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims (9)
- 인슐린을 저장하는 시린지와,프로그램된 제어 신호에 응답하여 일정한 압력을 상기 시린지에 부가하는 펌프와,상기 프로그램된 제어신호를 생성하여 상기 펌프에 전달하는 제어 디바이스와,인슐린의 공급모드를 전환시키기 위한 모드전환버튼과,인슐린의 주입을 명령하는 실행버튼을 구비하며,상기 제어디바이스는 제어프로그램을 저장하기 위한 메모리와 제어신호를 생성하는 콘트롤러를 구비하며, 상기 제어프로그램은 공복 시에 정상적 혈당을 유지하게 하는 기본모드와 음식을 섭취한 후 혈당을 정상 수준으로 유지시킬 수 있는 양의 인슐린을 한꺼번에 공급하는 식사모드와, 인슐린을 적절한 시간에 걸쳐 간헐적으로 공급하는 활성화모드를 포함하며, 상기 기본모드, 식사모드와 활성화모드 사이에서의 모드 전환은 상기 모드전환버튼에 의해 수행되며, 상기 제어디바이스의 콘트롤러는 상기 실행버튼의 활성화에 응답하여, 선택된 모드에 대응되는 프로그램된 제어신호를 상기 펌프로 전달하고, 상기 펌프의 작동에 의해 상기 시린지에 저장된 인슐린이 선택된 모드로 투여되는 인슐린 펌프.
- 제1항에 있어서, 상기 활성화모드가 5 - 6 시간에 걸쳐 매 6분 내지 8분에 걸쳐 인슐린을 간헐적으로 공급하는 인슐린 펌프.
- 통상적인 인슐린 펌프 치료 시에 필요한, 혈당을 일상적 상태로 유지할 수 있는 양을 지속적으로 주입하는 기본모드와 사용자가 음식을 섭취하였을 경우 인슐린을 공급할 것을 명령하는 식사모드로 구성되는 유지모드를 구동하는 신호를 생성하고, 활성화모드가 선택되었을 경우, 음식을 섭취한 후 신체 기능의 활성화를 통하여 혈당을 안정적으로 유지하고 당뇨병의 합병증을 예방할 수 있는 양의 인슐린을 적절한 시간에 걸쳐 간헐적으로 공급하도록 명령하는 신호를 생성하는 제어프로그램을 내장한 인슐린 펌프.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 인슐린이 속효성 인슐린인 인슐린 펌프.
- 제1항 내지 제4항 중 어느 한 항에 따른 인슐린 펌프와 병행하여 생리수 시린지 펌프를 포함하는 인슐린 투여 시스템.
- 제5항에 있어서, 상기 생리수 시린지 펌프는 생리수를 저장하는 시린지, 프로그램된 제어 신호에 응답하여 일정한 압력을 상기 시린지에 부가하는 펌프, 상기 프로그램된 제어신호를 생성하여 상기 펌프에 전달하는 제어 디바이스, 선택버튼, 인슐린 펌프를 장착하기 위한 장착대와, 상기 인슐린 펌프와의 동기화를 위한 접속 포트가 구비된 인슐린 투여 시스템.
- 제5항에 있어서, 상기 인슐린 펌프의 제어디바이스에 의해 생성된 제어신호가, 접속포트를 통해, 상기 생리수 시린지 펌프의 제어디바이스로 전달되고, 이 신호의 수신에 의해 상기 제어디바이스가 활성화되는 인슐린 투여 시스템.
- 제6항에 있어서, 상기 인슐린 펌프의 상기 생리수 시린지 펌프로의 장착이 접속포트에 의한 전기적 스위칭이 발생시키며, 생리수 시린지 펌프에 구비된 제어디바이스에 의해 인슐린 펌프가 제어되는 것을 특징으로 하는 인슐린 투여 시스템.
- 제8항에 있어서, 상기 생리수 시린지 펌프의 제어디바이스는 제어프로그램을 내장한 프로그램과 제어신호를 생성하기 위한 콘트롤러를 구비하며, 상기 제어프로그램은 인슐린공급을 제어하기 위한 모드와 생리수 공급을 제어하기 위한 모드를 동시에 구비하는 인슐린 투여 시스템.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040089241A KR100636336B1 (ko) | 2004-11-04 | 2004-11-04 | 혈당의 효율적 조절을 가능케 하는 삼중 기능을 갖는인슐린 펌프 및 이를 보조하는 생리수 시린지를 포함하는인슐린 투여 시스템 |
PCT/KR2005/003704 WO2006049446A1 (en) | 2004-11-04 | 2005-11-04 | Insulin pump having triple functions which enables efficient control of blood glucose concentration and insulin injection system comprising the same |
US11/667,168 US20080208173A1 (en) | 2004-11-04 | 2005-11-04 | Insulin Pump Having Triple Functions Which Enables Efficient Control of Blood Glucose Concentration and Insulin Injection System Comprising the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040089241A KR100636336B1 (ko) | 2004-11-04 | 2004-11-04 | 혈당의 효율적 조절을 가능케 하는 삼중 기능을 갖는인슐린 펌프 및 이를 보조하는 생리수 시린지를 포함하는인슐린 투여 시스템 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060040053A true KR20060040053A (ko) | 2006-05-10 |
KR100636336B1 KR100636336B1 (ko) | 2006-10-19 |
Family
ID=36319414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040089241A KR100636336B1 (ko) | 2004-11-04 | 2004-11-04 | 혈당의 효율적 조절을 가능케 하는 삼중 기능을 갖는인슐린 펌프 및 이를 보조하는 생리수 시린지를 포함하는인슐린 투여 시스템 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20080208173A1 (ko) |
KR (1) | KR100636336B1 (ko) |
WO (1) | WO2006049446A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160022422A (ko) * | 2014-08-19 | 2016-03-02 | 아주대학교산학협력단 | 부위마취 장치 및 방법 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10471207B2 (en) * | 2008-12-29 | 2019-11-12 | Medtronic Minimed, Inc. | System and/or method for glucose sensor calibration |
US8438898B2 (en) * | 2009-07-01 | 2013-05-14 | Edwards Lifesciences Corporation | Calibrant infusion fluid source preparation |
US8382703B1 (en) | 2011-10-18 | 2013-02-26 | King Saud University | Piezoelectric dual-syringe insulin pump |
CN103418053B (zh) * | 2013-07-24 | 2015-03-11 | 上海中医药大学附属龙华医院 | 个体化胰岛素治疗泵及其基础输注率优化方法 |
US20150032053A1 (en) | 2013-07-29 | 2015-01-29 | Medtronic, Inc. | Titration for medical infusion devices and systems |
CN105311702B (zh) * | 2014-09-03 | 2019-10-08 | 上海移宇科技股份有限公司 | 可抛式无导管药物输注系统 |
US10912881B2 (en) | 2015-04-27 | 2021-02-09 | Shane Maguire | Implantable infusion pumping catheter |
WO2017152346A1 (en) * | 2016-03-07 | 2017-09-14 | Medtrum Technologies Inc. | Tubeless fluid delivery system |
CN111317889B (zh) * | 2020-02-14 | 2022-06-24 | 微泰医疗器械(杭州)股份有限公司 | 一种胰岛素泵输注控制方法 |
US20220230718A1 (en) * | 2021-01-21 | 2022-07-21 | International Business Machines Corporation | Healthcare application insight velocity aid |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758467C2 (de) * | 1977-12-28 | 1985-04-04 | Siemens AG, 1000 Berlin und 8000 München | Vorrichtung zur vorprogrammierbaren Infusion von Flüssigkeiten |
IT1170375B (it) * | 1983-04-19 | 1987-06-03 | Giuseppe Bombardieri | Apparecchio che infonde insulina o glucosio nel soggetto diabetico sulla base di determinazioni di concentrazioni di glucosio ottenute senza bisogno di prelievi del sangue del paziente |
US4826810A (en) * | 1983-12-16 | 1989-05-02 | Aoki Thomas T | System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof |
FR2690622B1 (fr) * | 1992-04-29 | 1995-01-20 | Chronotec | Système de pompe à perfusion ambulatoire programmable. |
KR100301657B1 (ko) * | 1998-08-14 | 2001-10-27 | 최수봉 | 의사모드를가지는인슐린자동주사기의제어방법 |
US6549968B1 (en) * | 2000-03-31 | 2003-04-15 | Intel Corporation | Context transferring between portable computer processor and docking station processor upon docking and undocking |
KR100521855B1 (ko) * | 2003-01-30 | 2005-10-14 | 최수봉 | 무선교신이 가능한 인슐린펌프 제어방법 |
WO2005067604A2 (en) * | 2004-01-05 | 2005-07-28 | Oqo Incorporated | Docking station for mobile computing device |
US7469312B2 (en) * | 2005-02-24 | 2008-12-23 | International Business Machines Corporation | Computer system bus bridge |
US20070094435A1 (en) * | 2005-10-25 | 2007-04-26 | Fry Walter G | Computer docking system and method |
US7713262B2 (en) * | 2006-05-31 | 2010-05-11 | Calibra Medical, Inc. | Disposable infusion device with linear peristaltic pump |
-
2004
- 2004-11-04 KR KR1020040089241A patent/KR100636336B1/ko active IP Right Grant
-
2005
- 2005-11-04 WO PCT/KR2005/003704 patent/WO2006049446A1/en active Application Filing
- 2005-11-04 US US11/667,168 patent/US20080208173A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160022422A (ko) * | 2014-08-19 | 2016-03-02 | 아주대학교산학협력단 | 부위마취 장치 및 방법 |
US10183140B2 (en) | 2014-08-19 | 2019-01-22 | Ajou University Industry—Academic Cooperation Foundation | Apparatus and method for local anesthesia |
Also Published As
Publication number | Publication date |
---|---|
US20080208173A1 (en) | 2008-08-28 |
KR100636336B1 (ko) | 2006-10-19 |
WO2006049446A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080208173A1 (en) | Insulin Pump Having Triple Functions Which Enables Efficient Control of Blood Glucose Concentration and Insulin Injection System Comprising the Same | |
Strowig | Initiation and management of insulin pump therapy | |
EP0358709B1 (en) | Diabetic control by combined insulin forms | |
WO2009002455A1 (en) | Method and device for preventing hypoglycemia | |
WO2009004627A2 (en) | A device for drug delivery | |
US11642459B2 (en) | System and method for air removal | |
Selam et al. | Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients | |
Duckworth et al. | Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? | |
KR100723808B1 (ko) | 센서가 장착된 자동 제어 인슐린 펌프 | |
Skyler et al. | Optimizing pumped insulin delivery | |
Rosenstock | Insulin therapy: optimizing control in type 1 and type 2 diabetes | |
Kritz et al. | Implanted constant basal rate insulin infusion devices for type 1 (insulin-dependent) diabetic patients | |
KR100723806B1 (ko) | 인슐린 펌프의 인슐린 주입 제어방법 | |
Houdijk et al. | Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet‐or needle‐injection in patients with growth hormone deficiency | |
Pinelli et al. | Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint | |
Daugherty | Review of insulin therapy | |
Pickup et al. | Technology and the diabetic patient | |
Kraegen et al. | Pharmacokinetics of insulin implications for continuous subcutaneous insulin infusion therapy | |
JP2004000461A (ja) | インスリンを注入する装置 | |
ES2362420T3 (es) | Insulina para uso en un régimen de dosificación. | |
JP2016187629A (ja) | 代謝活性化療法の術前使用 | |
EP4091625A1 (en) | Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition | |
Saibene et al. | Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients | |
JPS61500710A (ja) | インシュリン供給アルゴリズム | |
Tamborlane | Portable Insulin Infusion Systems in Juvenile-Onset Diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121011 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131021 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140925 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160311 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161012 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171012 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181011 Year of fee payment: 13 |